Episode Details
Back to Episodes
Episode 452: ESMO 2025 - DV+ toripalimab in bladder cancer
Published 1 year ago
Description
Matt Galsky discusses the exciting Presidential session data from the Chinese phase 3 of DV+ toripalimab in advanced urothelial cancer.